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S U M M A R Y
Background: Over the last two to three decades there has been a marked decrease in certain bacterial
infections in Turkey. One of them is tuberculosis. Of note, statistics published by the Turkish Ministry of
Health (MoH) show decreasing pulmonary tuberculosis (PTB), but on the other hand, increasing
extrapulmonary tuberculosis (EPTB). The most common form of EPTB is tuberculous cervical
lymphadenitis (TCL). The increase in the number of TCL cases despite the decline in cases of PTB is
seen as a paradoxical issue. In contrast there has been an increase in the number of oropharyngeal
tularemia cases in the last decade in Turkey. The aim of this study was to draw attention to the
importance of differentiating between TCL and tularemia lymphadenitis, because these diseases may
have a similar histopathological appearance.
Methods: Thirty-two cases diagnosed as TCL were identiﬁed from the archives of a pathology laboratory
(Patomer Pathology Laboratory, Bursa, Turkey). PCR tests for Francisella tularensis and Mycobacterium
tuberculosis were carried out on the parafﬁn tissue blocks of these cases. At the same time, statistical data
on PTB and EPTB for the period 1996–2010 were retrieved from the MoH and reviewed. Statistics related
to tularemia, which has been diagnosed since 1988 and has been increasing in the last 10 years, were
obtained from the Department of Zoonoses of the MoH.
Results: Six out of 32 (19%) cases who had previously been diagnosed with ‘casseifying granulomatous
lymphadenitis consistent with tuberculosis’ were found to be positive for tularemia by PCR test of the
cervical lymph nodes.
Conclusions: Oropharyngeal tularemia should be kept in mind in the differential diagnosis of cervical
lymphadenitis in widespread geographic regions of the Northern Hemisphere, including the Asian
continent. In particular, if granulomatous inﬂammation with necrosis is seen histopathologically,
tularemia should be excluded before making the diagnosis of TCL.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Cervical lymphadenopathy is commonly seen in otorhinolar-
yngology, infectious diseases, and pediatric practice and by family
physicians. Tularemia may cause long-term lymphadenopathy in       
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http://dx.doi.org/10.1016/j.ijid.2013.09.004glandular, ulceroglandular, oculoglandular, or oropharyngeal
form. Oropharyngeal tularemia is observed after the ingestion
of contaminated food or water. Patients usually have a fever and
severe throat pain. On physical examination, unilateral or
bilateral exudative tonsillitis is seen. The tonsils may be lacerated.
Mucosal ulcers may also be seen in the mouth. Cervical
lymphadenopathy, unilateral or bilateral, may develop. By
enlarging and conglomerating, multiple lymph nodes may
become an egg-sized mass. Suppurative inﬂammation of the
lymph nodes may also occur.1–3 Oropharyngeal tularemia is the
dominant form of tularemia and occurs as a result of
the consumption of contaminated water (e.g., spring water,ociety for Infectious Diseases. Open access under CC BY-NC-ND license.
Figure 1. Microscopic view of casseiﬁed granulomatous lymphadenitis in case 27.
This case, who had previously been diagnosed with TCL, was now conﬁrmed to have
tularemia with PCR positivity for F. tularensis DNA (hematoxylin–eosin, 100).
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countries like Turkey.1–4
In oropharyngeal tularemia, the long duration of involvement
of the lymph nodes, which appear as large masses, may lead to
concern for a malignancy, such as lymphoma. This disease may
also be confused with chronic infectious diseases such as
tuberculosis (TB). Therefore, invasive interventions, like biopsy,
and other numerous medical tests are performed. Malignancy can
be excluded by histopathological examination. However, if the
lymph nodes reveal necrotizing granulomatous inﬂammation, the
patient may undergo unnecessary long-term anti-TB treatment
because this histological ﬁnding is usually considered sufﬁcient
proof for TB in an endemic area, which is a misconception. This
approach is common, especially in countries where routine
childhood bacille Calmette–Gue´rin (BCG) immunization pro-
grams causing puriﬁed protein derivative (PPD) positivity are
continued.4
For the last two to three decades there has been a marked
decrease in certain speciﬁc bacterial infections in Turkey. The most
important of these is TB. Interestingly, statistical analyses show
decreasing pulmonary tuberculosis (PTB) but increasing extra-
pulmonary tuberculosis (EPTB). The most common form of EPTB is
tuberculous cervical lymphadenitis (TCL). The increase in the
number of TCL cases despite the decline in cases of PTB is seen as a
paradoxical issue. In contrast, there has been an increase in the
number of oropharyngeal tularemia cases reported over the last
decade in Turkey.4
In this study, we performed a retrospective reevaluation of
cases previously diagnosed as TCL just by histological examination
showing granulomatous inﬂammation and PPD positivity, without
microbiological conﬁrmation.
2. Materials and methods
2.1. Samples
Samples were retrieved from the archives of a pathology
laboratory (Patomer Pathology Laboratory, Bursa, Turkey). Paraf-
ﬁn-embedded cervical lymph nodes that had been removed in ENT
clinics from 32 patients during the years 2006–2011 were included
in this study. Only lymph node material showing granulomatous
lymphadenitis and reported as being consistent with TCL was
included. There were no exclusion criteria other than an
insufﬁcient tissue sample for molecular study. These samples
had been ﬁxed in 3.7% formaldehyde solution and had been
processed and parafﬁn-embedded in the pathology laboratory.
Parafﬁn blocks were cut into 3–5-mm sections and stained with
hematoxylin and eosin.
2.2. DNA isolation
All samples were studied for Francisella tularensis DNA by PCR
in the Laboratory of Medical Microbiology of Kocaeli University.
DNA was extracted from two or three 25-mm sections of the
parafﬁn-embedded lymph node specimens.5 The Qiagen DNeasy
Blood and Tissue Kit was used for DNA isolation following the
deparafﬁnization procedure. Ampliﬁcation of the b-actin house-
keeping gene was performed on all samples to ensure the
presence of intact DNA.
2.3. Real-time TaqMan PCR
DNA ampliﬁcation of F. tularensis was performed by real-time
TaqMan PCR using previously published primer and probe sets
targeting the ISFtu2 gene.5,6 The primer and probe sets targeting
the ISFtu2 genome were as follows: sense primer 50-ACAAGAAGT-CATGCTTGATTCAAC-30, anti-sense primer 50-GGATTACCTAAAG-
CATCAGTCATAGC-30, probe sequence ATAGCAAGAGCACAT (Dye 6-
FAM).
Reactions were run in 25-ml volumes containing 2 ml of sample
DNA. The ﬁnal MgCl2 concentration was 5 mM, whereas the
primers and probes were 500 nM and 100 nM, respectively. The
annealing temperature for the TaqMan assay was 60 8C. TaqMan
PCR conditions were as follows: activation was one cycle of 95 8C
for 3 min, and ampliﬁcation and detection was 40 cycles of 94 8C
for 10 s and 65 8C for 30 s.
Positive and negative DNA controls were used in all PCR
experiments. Two types of control were used on each PCR plate in
all PCR experiments. F. tularensis subsp. holarctica NCTC 10857 was
used as positive control. Reagent blanks and Brucella DNA were
used as negative controls.
All samples were also screened for Mycobacterium tuberculosis.
Primers rpo95 (50-CCACCCAGGACGTGGAGGCGATCACACCG-30)
and rpo397 (50-GTCAACCCGTTCGGGTTCATCGAAACG-30) were
used to amplify a 329-bp product, which includes the relevant
segment of rpoB.7
Statistical data on PTB and EPTB for the period 1996–2010 were
retrieved from the Turkish Ministry of Health (MoH) and
reviewed.8 Statistics related to tularemia, which has been
diagnosed since 1988 and has been increasing in the last 10
years, were obtained from the Department of Zoonoses of the MoH.
3. Results
The patients were aged between 17 and 77 years (mean 49
years); 11 were male (34.3%) and 21 were female (65.7%).
Histopathological examination of the slides revealed lymph nodes
with necrosis and granulomatous inﬂammation (Figure 1). Al-
though acid-fast staining was negative for acid–alcohol-resistant
bacilli (AARB) in all cases, the histopathological diagnosis was
considered and reported to be casseifying granulomatous inﬂam-
mation consistent with TB. The presence of F. tularensis DNA in the
cervical lymph node tissue samples was shown by real-time
TaqMan PCR in six of the 32 cases (19%). All six F. tularensis PCR-
positive lymph nodes were negative for M. tuberculosis PCR and
were also negative for AARB (Table 1).
Statistical data from the Department of Zoonoses, MoH
regarding cases of TB and tularemia in Turkey indicated decreasing
numbers of PTB and increasing numbers of EPTB and tularemia
(Table 2).
Table 1
PCR test results for TB and tularemia in AARB-negative cases showing granulomatous lymphadenitis histopathologically
Case Age, years Sex M. tuberculosis PCR F. tularensis PCR Case Age, years Sex M. tuberculosis PCR F. tularensis PCR
1 75 F Negative Negative 17 4 F Negative Negative
2 42 F Negative Negative 18 77 F Negative Negative
3 17 M Positive Negative 19 59 F Negative Negative
4 54 F Positive Negative 20 46 F Positive Negative
5 69 F Negative Negative 21 29 M Negative Negative
6 61 F Negative Negative 22 38 F Positive Negative
7 68 F Negative Positive 23 31 M Negative Negative
8 51 M Positive Negative 24 54 F Positive Negative
9 37 F Negative Negative 25 27 F Negative Negative
10 22 M Negative Positive 26 68 M Positive Negative
11 44 M Positive Negative 27 36 M Negative Positive
12 39 F Negative Negative 28 52 F Negative Negative
13 62 F Negative Negative 29 55 F Negative Negative
14 71 F Positive Negative 30 79 M Positive Negative
15 53 M Negative Positive 31 77 F Positive Negative
16 49 M Negative Positive 32 25 F Negative Positive
TB, tuberculosis; AARB, acid–alcohol-resistant bacilli; F, female; M, male.
Table 2
Annual distribution of PTB, EPTB, and tularemia cases in Turkey between the years
2005 and 20108
Year PTB cases, n EPTB (mostly TCL) cases, n (%)a Tularemia cases, n
2005 20 535 1622 (7.9) 374
2006 20 526 1668 (8.1) 133
2007 19 694 1913 (9.7) 86
2008 18 450 1917 (10.4) 70
2009 17 402 2036 (11.7) 428
2010 NP NP 1519
PTB, pulmonary tuberculosis; EPTB, extrapulmonary tuberculosis; TCL, tuberculous
cervical lymphadenitis; NP, not yet published.
a %: EPTB/(PTB + EPTB).
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Suppurative inﬂammation and abscess formation is one of the
most common complications of tularemia. If treatment is started in
the ﬁrst 3 weeks of the disease, this complication may be avoided.
However, since oropharyngeal tularemia cases are often consid-
ered to be streptococcal tonsillitis at ﬁrst presentation, the disease
is often treated with penicillins or other beta-lactam antibiotics
(ampicillin–sulbactam, amoxicillin–clavulanic acid, cephalospor-
ins, etc.). The second mistake made in these patients is changing
the treatment to another antibiotic or extending the treatment
duration due to unresponsiveness. As a result, it takes a few weeks
to months to make a diagnosis of tularemia in most patients. With
unresponsiveness to these treatment modalities, multiple lymph-
adenopathies may occur in the head and neck region. Because of
the fear and suspicion of malignancy, probable tularemia patients
are directed to ENT or other surgery clinics. Since tularemia is not
kept in mind, the patient may undergo surgical lymph node
excision. Moreover, due to the granulomatous inﬂammation on
histopathological examination, the diagnosis of TCL is often made,
which is another misdiagnosis for the tularemia patient.4,9,11,12
The total number of TB cases seems to be decreasing deﬁnitively
in Turkey.8 Despite all these improvements, a signiﬁcant increase
in the numbers of TCL and EPTB cases was observed between the
years 2005 and 2010, which cannot be explained easily. After
careful evaluation, a steady growth in the number of diagnoses of
EPTB versus PTB was observed during the same period.
With regard to the range of patient ages, the age-group 15–34
years appears to be predominant. With this in mind, the
correctness of the diagnosis of TCL should be evaluated. It seems
that granulomatous lymphadenitis is one of the main histopatho-
logical features in oropharyngeal tularemia, as in TB. The fact thatnecrosis, frequently mimicking casseiﬁcation necrosis, may also be
seen in tularemia, makes it particularly crucial to differentiate TCL
from tularemia lymphadenitis.9–12
According to many clinicians, for the diagnosis of TCL in daily
practice in TB endemic and low income countries, it is usually
sufﬁcient to see casseiﬁcation necrosis in excisional biopsies of
the lymph nodes and to report the histopathological diagnosis as
‘casseifying granulomatous lymphadenitis’. Bacteriological
investigations (smear, culture) of these samples usually give
negative results due to the small number of bacteria. The PCR
study for M. tuberculosis in tissue samples also gives negative
results in half of the cases.13 Therefore this test is available in a
limited number of medical centers. It is also important to keep in
mind that PPD positivity is very common in countries like Turkey
where the BCG vaccine is routinely applied. So, PPD positivity
does not always mean neither latent nor active TB infection in
such countries.
Mycobacterial disease may present with the same kind of local
lymphadenopathy as tularemia, although at a much slower rate of
development. It is evident that the diagnosis of ‘casseifying
granulomatous lymphadenitis’ is not sufﬁcient to differentiate
between TCL and tularemia, since the same histopathological
features may be present in both of these diseases. The presence of
casseifying necrosis, no neutrophils, and, occasionally, intracellular
and/or extracellular AARB in granulomas are the ﬁndings in TCL.
On the other hand, the borders of granulomas in tularemia are not
sharp and fewer giant cells are seen inside them.9
The histopathological features of TCL are closely related to the
duration of the disease. In the hyper-acute period, reactive
follicular hyperplasia, non-necrotizing granulomas, and diffuse
histiocytes may be seen. Abscess formation occurs in the second
week and necrosis becomes prominent in the fourth week. On the
other hand, necrosis may be seen in the very early period, such as
on the ﬁfth day after the onset of symptoms. Suppurative
inﬂammation of the lymph nodes involved may also occur after
speciﬁc antibiotherapy is started. The granulomatous inﬂamma-
tion surrounding the necrosis consists of foamy and/or epithelioid
histiocytes and occasional giant cells. In most cases, the
inﬂammatory process may expand out of the lymph nodes. Silver
staining procedures (Steiner, Dieterle, and Warthin–Starry) may
show the microorganisms located inside the macrophages. The
direct ﬂuorescein antibody test and PCR tests may be done with
aspiration material. Since PCR may also give positive results after
antibiotherapy, it is a useful test.
In the differential diagnosis of necrotizing lymphadenitis the
following must be considered: staphylococcal and streptococcal
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toxoplasmosis, lymphoma, brucellosis, and tularemia, even though
the prevalence rates of this disease are lower.11
In regions with epidemic tularemia, we strongly believe that
patients diagnosed with TCL by histopathology alone and who are
not responding to treatment or who are experiencing an atypical
course, should be investigated for tularemia. In patients with
unilateral or bilateral lymphadenopathy and a history of acute
tonsillopharyngitis that is unresponsiveness to beta-lactams,
tularemia should be considered in the differential diagnosis, even
in regions where tularemia has not previously been reported.
The frequency of certain speciﬁc infectious diseases including
TB is decreasing in Turkey. However, while the total number of TB
cases is decreasing, the proportion of EPTB cases (mostly TCL) is
noticeably increasing. Meanwhile, the number of tularemia cases
has also increased over the last two decades (1988–2011) due to
unexplained reasons, and this is a paradoxical issue.8,10,11,14–17
In a very recent study, Karabay et al. investigated the presence
of anti-tularemia antibodies by tularemia microagglutination test
in patients diagnosed with TCL in a country-wide setting in
Turkey.17 The study showed 10–20-times more anti-tularemia
antibody-positive cases in the TCL group than in the control group.
The fact that the study was carried out over a wide area endemic
for both tularemia and TB with a high number of cases (1170 TCL
cases) and controls (596 healthy volunteers) makes the results of
the study more signiﬁcant. Our study was mainly based on the
molecular detection of F. tularensis in cervical lymph node tissue
samples previously diagnosed as TCL and makes another strong
contribution to resolving the issue of overdiagnosis of TCL due to
histopathological examination results, instead of the diagnosis of
oropharyngeal tularemia, in areas endemic for both TB and
tularemia. To the best of our knowledge our study is the ﬁrst
original study to show the importance of F. tularensis DNA
screening in human cases previously diagnosed as TCL only by
histopathology. A number of studies conducted in Europe and Asia,
including the ﬁrst one in 1997 by Sjostedt et al., have shown the
PCR ampliﬁcation of F. tularensis DNA in different tissues.18,19
Lamps et al. found 14 of 15 (93%) human and non-human primate
cases to be positive for F. tularensis DNA by PCR analysis. F.
tularensis DNA was detected in all the types of tissue tested,
including lymph, liver, spleen, kidney, heart, lung, meninges, and
gut.5 Versage et al. tested the ability of the ISFtu2, tul4, and 23kDa
TaqMan assays to identify F. tularensis in biological specimens from
infected mouse tissues. Whereas the DNA isolated from the spleens
and livers of control mice were negative in the assays, DNA isolated
from the tissues of F. tularensis-infected mice were consistently
positive by all three assays. In addition, tissue samples spiked with
known concentrations of F. tularensis DNA showed no evidence of
inhibition. They also reported that the combined ISFtu2, 23kDa,
and tul4 TaqMan assay accurately detected F. tularensis in 46 of the
46 carcasses (100%). None of the 40 (0%) F. tularensis-negative
tissues were positive by the TaqMan assays. Despite the challenges
associated with culturing F. tularensis from carcasses, the multi-
target TaqMan assay detected F. tularensis in 100% of cases,
demonstrating that the multi-target TaqMan assay is useful for the
detection of F. tularensis in complex specimens.20
In most European countries including Germany, those of the
Balkan Peninsula, and many East European countries, the increase
in tularemia cases is also drawing attention.21–23 Tularemia is
thought to be one of the diseases whose epidemiological features
are changing owing to varying climate conditions, or, in more
popular terms, global warming. This means that the classical
deﬁnitions that are used to describe tularemia, such as ‘‘a zoonotic
disease seen in the Northern Hemisphere between the 30th and
71st latitudes’’ is changing. In other words, with its recent
increasing potential, tularemia may be a threat to a largerpopulation living over a widespread geographical area in the near
future. Tularemia may become an infectious disease affecting
people living not only in North America, Europe, and the Balkan
Peninsula, but also Russia, the Turkic Republics of Central Asia,
China, India, and Japan. This shows how important tularemia is in
the differential diagnosis in such a wide geographical area, where
PTB and EPTB are common. It has been reported that patients with
tularemia may be being misdiagnosed and treated for TCL in
centers not only in Turkey,12 but also in other countries endemic
for both TB and tularemia. This situation may inevitably lead to
unnecessary long-term (6 months) anti-TB treatment,12 with its
many side effects. However, the clinical suspicion of tularemia may
lead to an early diagnosis of the disease and treatment with
appropriate antibiotics; 10–21 days of streptomycin, gentamicin,
ciproﬂoxacin, doxycycline, or chloramphenicol may be efﬁcient
and sufﬁcient.
A limitation of this study is that it was mainly based on cervical
lymph node tissue specimens archived as consistent with TCL after
histopathological examination in a private pathology laboratory.
Our study did not include clinical or epidemiological data. We have
no information at this time on TB culture of fresh lymph node
samples. We did not have information on the patients’ response to
anti-TB drugs. The results have to be considered from the
histopathological and microbiological point of view.
In conclusion, to avoid misdiagnosis and unnecessary TB
treatment, we suggest that patients with cervical lymphadenitis
and a neck mass and/or history of tonsillopharyngitis in the
gradually expanding endemic area should be evaluated for
tularemia.4,11,24 If casseifying granulomatous lymphadenitis is
present, then risk factors and contacts related to TB and tularemia,
especially oropharyngeal tularemia and other glandular forms of
tularemia (glandular, ulceroglandular, oculoglandular), should be
determined by taking a detailed history, the patient should be
investigated for a BCG scar, bacteriological isolation studies
besides pathological examination should be carried out, if possible
PCR tests for TB and tularemia should be done, agglutination tests
for tularemia should be applied, and tuberculin testing and/or
interferon-gamma release tests (Quantiferon and T-SPOT.TB) for
TB should be done. We suggest that the differential diagnosis of
granulomatous lymphadenitis cases is made by common consen-
sus of experts from pathology, infectious diseases, otorhinolaryn-
gology, pulmonary diseases, and also internal medicine.
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